Product Categories
| Country: | China |
|---|---|
| Tel: | 010-88755821 |
| Mobile: | 13911359480 |
| E-mail: | sophia_818@126.com |
| QQ: | 284050068 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Adenosine disodium triphosphate | C10H17N5NaO13P3 | 987-65-5 | Details |
| 1-(3-Bromo-2-methoxyphenyl)ethanone | C9H9BrO2 | 267651-23-0 | Details |
| 3-Bromo-2-hydroxyacetophenone | C8H7BrO2 | 1836-05-1 | Details |
| 2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one | C30H35N5O3 | 184177-83-1 | Details |
| (5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester | C21H21F2N3O4S | 149809-43-8 | Details |
| Nicotinic acid | C6H5NO2 | 59-67-6 | Details |
| Nicotinamide | C6H6N2O | 98-92-0 | Details |
| Isavuconazole | C22H17F2N5OS | 241479-67-4 | Details |
| 2-(methylamino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate | C15H23N3O4 | 1180002-01-0 | Details |
| 1-(((2R,3S)-2-(2,5-difluorophenyl)-3-Methyloxiran-2-yl)Methyl)-1H-1,2,4-triazole | C12H11F2N3O | 241479-73-2 | Details |
| (αS,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanenitrile | C13H12F2N4O | 241479-74-3 | Details |
| Isosulfan Blue | C27H31N2NaO6S2 | 68238-36-8 | Details |
| 4-Chloro-3-formylbenzenesulfonic acid | C7H5ClO4S | 60767-69-3 | Details |
| 4-AMino-5-Methylpyridin-2-ol | C6H8N2O | 95306-64-2 | Details |
| 4-CYANO-2-METHOXYBENZALDEHYDE | C9H7NO2 | 21962-45-8 | Details |
| 2-Cyanoethyl 3-oxobutanoate | C7H9NO3 | 65193-87-5 | Details |
| (Z)-2-cyanoethyl 2-(4-cyano-2-methoxybenzylidene)-3-oxobutanoate | C16H14N2O4 | 1050477-39-8 | Details |
| Efinaconazole | C18H22F2N4O | 164650-44-6 | Details |
| (2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol Mesylate | C13H15F2N3O4S | 1175536-50-1 | Details |
| 4-Methylenepiperidine HCl | C6H12ClN | 144230-50-2 | Details |
| Nafamostat mesylate | C21H25N5O8S2 | 82956-11-4 | Details |
| 6-Cyano-2-naphthol | C11H7NO | 52927-22-7 | Details |
| Upadacitinib hemihydrate | C17H21F3N6O2 | 2050057-56-0 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| (3R,4S)-4-ethyl-1,3-Pyrrolidinedicarboxylic acid 1-(phenylmethyl) ester | C15H19NO4 | 1428243-24-6 | Details |
| (3R,4S)-3-(2-Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethy! ester | C16H20BrNO3 | 1428243-26-8 | Details |
| N-[5-[(4-Methylphenyl)sulfony!]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic, acid 1, 1-dimethylethyl ester | C18H20N4O4S | 1201187-44-1 | Details |
| N-[5-[(4-Methylphenyl)sulfony!]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic. acid ethyl ester | C16H16N4O4S | 1869118-24-0 | Details |
| DMSO | C2H6OS | 67-68-5 | Details |
| C9H6Cl2N2 | 39576-82-4 | Details |
| C9H18N2O2 | 122536-77-0 | Details |
| C22H25N3O5 | 2212021-83-3 | Details |
| C23H28FN5O3 | 2212021-61-7 | Details |
| C10H13N5O | 1637-39-4 | Details |
| Monomethyl Auristatin E | C39H67N5O7 | 474645-27-7 | Details |
| 18-Bromo-1-octadecene | C18H35Br | 172656-11-0 | Details |
| 3,4-Dimethoxybenzaldehyde | C9H10O3 | 120-14-9 | Details |
| Z-BETA-GLU(OTBU)-OH | C17H23NO6 | 118247-88-4 | Details |
| 4-Methoxyphenylhydrazine hydrochloride | C7H11ClN2O | 19501-58-7 | Details |
| Minoxidil | C9H15N5O | 38304-91-5 | Details |
| Dimethyl sulfone | C2H6O2S | 67-71-0 | Details |
| (R)-3-(cyclopropylsulfonyl-1.2.3.4.4a,5-hexahydrobenzoblpyrazinol1,2-d1,4 oxazin-8-amine | C14H19N3O3S | 2489438-07-3 | Details |
| C24H19F2N3O4S | 1985605-59-1 | Details |
| C12H20N4O6S | 1174018-99-5 | Details |
| C23H36N4O4 | 1510832-19-5 | Details |
| C30H30F2N6O3 | 2296729-00-3 | Details |
| C16H14ClFN4O2 | 2252403-82-8 | Details |
| C16H14ClFN4O2 | 2300966-23-6 | Details |
| C6H3Cl2FN2O | 113237-20-0 | Details |
| C9H14N2 | 1698293-93-4 | Details |
| C18H18FN5O2 | 1802220-02-5 | Details |
| C17H17FN4O3 | 1802221-21-1 | Details |
| C8H17NO3 | 119768-44-4 | Details |
| C8H10FNO | 1228570-33-9 | Details |
| C20H22N8O3 | 1609392-27-9 | Details |
| C5H5Cl2LiN2O3 | 2245111-15-1 | Details |
| C5H3Cl2LiN2O2 | 2245238-80-4 | Details |
| C7H8N2O4 | 1352925-63-3 | Details |
| C10H9ClN4O3 | 2245111-21-9 | Details |
| C10H12N4O | 1609394-10-6 | Details |
| C28H28F2N6O3 | 1289023-67-1 | Details |
| C28H30F2N6O7S | 1374024-48-2 | Details |
| C10H11NO2 | 1190363-44-0 | Details |
| C19H31NO2Si | 1190363-45-1 | Details |
| C25H37ClF2N2OSi | 1373116-04-1 | Details |
| C25H36F2N2OSi | 1289024-42-5 | Details |
| C16H17ClF2N2O | 1373116-07-4 | Details |
| C16H16F2N2O | 1373116-05-2 | Details |
| C15H16N6O2 | 1373116-06-3 | Details |
| C19H19ClN6O2 | 1297538-32-9 | Details |
| C10H6ClN3 | 1297537-37-1 | Details |
| C13H13ClN4 | 1297537-41-7 | Details |
| C6H6N2O3 | 1297537-45-1 | Details |
| C22H21F4N5O3 | 2101700-15-4 | Details |
| C3H8ClF3N2 | 2764851-03-6 | Details |
| C16H14FNO4 | 1571888-11-3 | Details |
| C19H14FN3O3 | 2642629-19-2 | Details |
| C48H48F2N10O5 | 2212020-52-3 | Details |
| 2-(benzo[d][1,3]dioxol-5-yl)ethanamine | C9H11NO2 | 1484-85-1 | Details |
| C16H19NO3 | 2212021-78-6 | Details |
| C7H16ClN | 1897428-40-8 | Details |
| Ethyl2-chloro-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)- 1H-pyrazol-1-yl)nicotinate | C16H17ClF3N3O3 | 2229861-21-4 | Details |
| C225H348N48O68 | 2023788-19-2 | Details |
| 1,3-Dimethyl-1H-pyrazole-4-sulfonamide | C5H9N3O2S | 8898-53-2 | Details |
| Lithium Edoxaban Intermediate C | C7H6ClLiN2O3 | 480450-83-7 | Details |
| C7H6O3S | 4066-41-5 | Details |
| C8H6BrFN2 | 1784678-61-0 | Details |
| Edoxaban Intermediate A8 | C14H25N5O3 | 480450-69-9 | Details |
| 2-Chloro-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)- 1H-pyrazol-1-yl)nicotinic acid | C14H13ClF3N3O3 | 2229861-17-8 | Details |
| 2-Chloro-N-(1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3- 1 (3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1- yl)nicotinamide | C19H20ClF3N6O4S | 2229861-18-9 | Details |
| C28H31N3O2 | 2212021-81-1 | Details |
| Retatrutide | 2381089-83-2 | Details |
| Dopamine hydrochloride | C8H12ClNO2 | 62-31-7 | Details |
| C26H26ClF2N7O | 2212022-57-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 | ||||